Market accessRegistration and reimbursement are the most critical steps in the introduction of a new medicinal product.
Registration and reimbursement are the most critical steps in the introduction of a new medicinal product. Certainly in a country such as The Netherlands, where patients do not expect to make an extra payment for healthcare products, full reimbursement is essential.
Titus Health Care makes an analysis of the registration and reimbursement possibilities together with specialist business partners and proposes diverse strategies for successful implementation of the registration process and reimbursement application. Our outstanding relations with key opinion leaders and leading gynaecology clinics is of great importance in this process.
Since 2014 Titus Health Care has been in possession of a pharmaceutical wholesale license, allowing the autonomous import and distribution of medical products for the EU.
In 2012 Titus Health Care introduced the medicinal product Esmya in The Netherlands on behalf of manufacturer Gedeon Richter.